White Paper
Parkview Health
To improve patient outcomes and increase health equity, Parkview Health has brought Digital Diagnostics’ FDA cleared artificial intelligence system, LumineticsCore™ (formerly IDx-DR), to the point-of-care to improve comprehensive diabetes management through the autonomous detection of diabetic retinopathy (including macular edema).
Read this white paper to find out more about Parkview Health and LumineticsCore
- 3 lab and endo facilities providing LumineticsCore exams at the point-of-care
- 326 patients tested for diabetic retinopathy eye disease using LumineticsCore in 2021
- 46% of patients tested positive for diabetic eye disease
Download White Paper
Fill out this form to download the Parkview Health white paper